IBDEI0RR ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12495,0)
;;=R39.2^^49^603^26
;;^UTILITY(U,$J,358.3,12495,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12495,1,3,0)
;;=3^Extrarenal Uremia
;;^UTILITY(U,$J,358.3,12495,1,4,0)
;;=4^R39.2
;;^UTILITY(U,$J,358.3,12495,2)
;;=^5019348
;;^UTILITY(U,$J,358.3,12496,0)
;;=R30.1^^49^603^57
;;^UTILITY(U,$J,358.3,12496,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12496,1,3,0)
;;=3^Vesical Tenesmus
;;^UTILITY(U,$J,358.3,12496,1,4,0)
;;=4^R30.1
;;^UTILITY(U,$J,358.3,12496,2)
;;=^5019323
;;^UTILITY(U,$J,358.3,12497,0)
;;=Z85.46^^49^603^28
;;^UTILITY(U,$J,358.3,12497,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12497,1,3,0)
;;=3^Hx of Malig Neop of Prostate
;;^UTILITY(U,$J,358.3,12497,1,4,0)
;;=4^Z85.46
;;^UTILITY(U,$J,358.3,12497,2)
;;=^5063423
;;^UTILITY(U,$J,358.3,12498,0)
;;=N18.1^^49^603^7
;;^UTILITY(U,$J,358.3,12498,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12498,1,3,0)
;;=3^Chr Kidney Disease,Stage 1
;;^UTILITY(U,$J,358.3,12498,1,4,0)
;;=4^N18.1
;;^UTILITY(U,$J,358.3,12498,2)
;;=^5015602
;;^UTILITY(U,$J,358.3,12499,0)
;;=N18.2^^49^603^8
;;^UTILITY(U,$J,358.3,12499,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12499,1,3,0)
;;=3^Chr Kidney Disease,Stage 2
;;^UTILITY(U,$J,358.3,12499,1,4,0)
;;=4^N18.2
;;^UTILITY(U,$J,358.3,12499,2)
;;=^5015603
;;^UTILITY(U,$J,358.3,12500,0)
;;=N18.4^^49^603^12
;;^UTILITY(U,$J,358.3,12500,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12500,1,3,0)
;;=3^Chr Kidney Disease,Stage 4
;;^UTILITY(U,$J,358.3,12500,1,4,0)
;;=4^N18.4
;;^UTILITY(U,$J,358.3,12500,2)
;;=^5015605
;;^UTILITY(U,$J,358.3,12501,0)
;;=N18.5^^49^603^13
;;^UTILITY(U,$J,358.3,12501,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12501,1,3,0)
;;=3^Chr Kidney Disease,Stage 5
;;^UTILITY(U,$J,358.3,12501,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,12501,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,12502,0)
;;=N18.6^^49^603^17
;;^UTILITY(U,$J,358.3,12502,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12502,1,3,0)
;;=3^ESRD
;;^UTILITY(U,$J,358.3,12502,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,12502,2)
;;=^303986
;;^UTILITY(U,$J,358.3,12503,0)
;;=N18.9^^49^603^14
;;^UTILITY(U,$J,358.3,12503,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12503,1,3,0)
;;=3^Chr Kidney Disease,Unspec
;;^UTILITY(U,$J,358.3,12503,1,4,0)
;;=4^N18.9
;;^UTILITY(U,$J,358.3,12503,2)
;;=^332812
;;^UTILITY(U,$J,358.3,12504,0)
;;=N17.8^^49^603^2
;;^UTILITY(U,$J,358.3,12504,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12504,1,3,0)
;;=3^Acute Kidney Failure,Other
;;^UTILITY(U,$J,358.3,12504,1,4,0)
;;=4^N17.8
;;^UTILITY(U,$J,358.3,12504,2)
;;=^5015601
;;^UTILITY(U,$J,358.3,12505,0)
;;=N25.89^^49^603^29
;;^UTILITY(U,$J,358.3,12505,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12505,1,3,0)
;;=3^Impaired Renal Tubular Function Disorder NEC
;;^UTILITY(U,$J,358.3,12505,1,4,0)
;;=4^N25.89
;;^UTILITY(U,$J,358.3,12505,2)
;;=^5015618
;;^UTILITY(U,$J,358.3,12506,0)
;;=N27.1^^49^603^54
;;^UTILITY(U,$J,358.3,12506,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12506,1,3,0)
;;=3^Small Kidney,Bilateral
;;^UTILITY(U,$J,358.3,12506,1,4,0)
;;=4^N27.1
;;^UTILITY(U,$J,358.3,12506,2)
;;=^5015624
;;^UTILITY(U,$J,358.3,12507,0)
;;=N20.1^^49^603^6
;;^UTILITY(U,$J,358.3,12507,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12507,1,3,0)
;;=3^Calculus of Ureter
;;^UTILITY(U,$J,358.3,12507,1,4,0)
;;=4^N20.1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RR 3774 printed Sep 23, 2025@19:30:29 Page 2
IBDEI0RR ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12495,0)
+2 ;;=R39.2^^49^603^26
+3 ;;^UTILITY(U,$J,358.3,12495,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,12495,1,3,0)
+6 ;;=3^Extrarenal Uremia
+7 ;;^UTILITY(U,$J,358.3,12495,1,4,0)
+8 ;;=4^R39.2
+9 ;;^UTILITY(U,$J,358.3,12495,2)
+10 ;;=^5019348
+11 ;;^UTILITY(U,$J,358.3,12496,0)
+12 ;;=R30.1^^49^603^57
+13 ;;^UTILITY(U,$J,358.3,12496,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,12496,1,3,0)
+16 ;;=3^Vesical Tenesmus
+17 ;;^UTILITY(U,$J,358.3,12496,1,4,0)
+18 ;;=4^R30.1
+19 ;;^UTILITY(U,$J,358.3,12496,2)
+20 ;;=^5019323
+21 ;;^UTILITY(U,$J,358.3,12497,0)
+22 ;;=Z85.46^^49^603^28
+23 ;;^UTILITY(U,$J,358.3,12497,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,12497,1,3,0)
+26 ;;=3^Hx of Malig Neop of Prostate
+27 ;;^UTILITY(U,$J,358.3,12497,1,4,0)
+28 ;;=4^Z85.46
+29 ;;^UTILITY(U,$J,358.3,12497,2)
+30 ;;=^5063423
+31 ;;^UTILITY(U,$J,358.3,12498,0)
+32 ;;=N18.1^^49^603^7
+33 ;;^UTILITY(U,$J,358.3,12498,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,12498,1,3,0)
+36 ;;=3^Chr Kidney Disease,Stage 1
+37 ;;^UTILITY(U,$J,358.3,12498,1,4,0)
+38 ;;=4^N18.1
+39 ;;^UTILITY(U,$J,358.3,12498,2)
+40 ;;=^5015602
+41 ;;^UTILITY(U,$J,358.3,12499,0)
+42 ;;=N18.2^^49^603^8
+43 ;;^UTILITY(U,$J,358.3,12499,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,12499,1,3,0)
+46 ;;=3^Chr Kidney Disease,Stage 2
+47 ;;^UTILITY(U,$J,358.3,12499,1,4,0)
+48 ;;=4^N18.2
+49 ;;^UTILITY(U,$J,358.3,12499,2)
+50 ;;=^5015603
+51 ;;^UTILITY(U,$J,358.3,12500,0)
+52 ;;=N18.4^^49^603^12
+53 ;;^UTILITY(U,$J,358.3,12500,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,12500,1,3,0)
+56 ;;=3^Chr Kidney Disease,Stage 4
+57 ;;^UTILITY(U,$J,358.3,12500,1,4,0)
+58 ;;=4^N18.4
+59 ;;^UTILITY(U,$J,358.3,12500,2)
+60 ;;=^5015605
+61 ;;^UTILITY(U,$J,358.3,12501,0)
+62 ;;=N18.5^^49^603^13
+63 ;;^UTILITY(U,$J,358.3,12501,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,12501,1,3,0)
+66 ;;=3^Chr Kidney Disease,Stage 5
+67 ;;^UTILITY(U,$J,358.3,12501,1,4,0)
+68 ;;=4^N18.5
+69 ;;^UTILITY(U,$J,358.3,12501,2)
+70 ;;=^5015606
+71 ;;^UTILITY(U,$J,358.3,12502,0)
+72 ;;=N18.6^^49^603^17
+73 ;;^UTILITY(U,$J,358.3,12502,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,12502,1,3,0)
+76 ;;=3^ESRD
+77 ;;^UTILITY(U,$J,358.3,12502,1,4,0)
+78 ;;=4^N18.6
+79 ;;^UTILITY(U,$J,358.3,12502,2)
+80 ;;=^303986
+81 ;;^UTILITY(U,$J,358.3,12503,0)
+82 ;;=N18.9^^49^603^14
+83 ;;^UTILITY(U,$J,358.3,12503,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,12503,1,3,0)
+86 ;;=3^Chr Kidney Disease,Unspec
+87 ;;^UTILITY(U,$J,358.3,12503,1,4,0)
+88 ;;=4^N18.9
+89 ;;^UTILITY(U,$J,358.3,12503,2)
+90 ;;=^332812
+91 ;;^UTILITY(U,$J,358.3,12504,0)
+92 ;;=N17.8^^49^603^2
+93 ;;^UTILITY(U,$J,358.3,12504,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,12504,1,3,0)
+96 ;;=3^Acute Kidney Failure,Other
+97 ;;^UTILITY(U,$J,358.3,12504,1,4,0)
+98 ;;=4^N17.8
+99 ;;^UTILITY(U,$J,358.3,12504,2)
+100 ;;=^5015601
+101 ;;^UTILITY(U,$J,358.3,12505,0)
+102 ;;=N25.89^^49^603^29
+103 ;;^UTILITY(U,$J,358.3,12505,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,12505,1,3,0)
+106 ;;=3^Impaired Renal Tubular Function Disorder NEC
+107 ;;^UTILITY(U,$J,358.3,12505,1,4,0)
+108 ;;=4^N25.89
+109 ;;^UTILITY(U,$J,358.3,12505,2)
+110 ;;=^5015618
+111 ;;^UTILITY(U,$J,358.3,12506,0)
+112 ;;=N27.1^^49^603^54
+113 ;;^UTILITY(U,$J,358.3,12506,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,12506,1,3,0)
+116 ;;=3^Small Kidney,Bilateral
+117 ;;^UTILITY(U,$J,358.3,12506,1,4,0)
+118 ;;=4^N27.1
+119 ;;^UTILITY(U,$J,358.3,12506,2)
+120 ;;=^5015624
+121 ;;^UTILITY(U,$J,358.3,12507,0)
+122 ;;=N20.1^^49^603^6
+123 ;;^UTILITY(U,$J,358.3,12507,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,12507,1,3,0)
+126 ;;=3^Calculus of Ureter
+127 ;;^UTILITY(U,$J,358.3,12507,1,4,0)
+128 ;;=4^N20.1
